143 related articles for article (PubMed ID: 22609380)
1. Causality methods in cosmetovigilance: comparison of Colipa and PLM versus global introspection.
Zweers PG; Gilmour NJ; Hepburn PA; Gerritsen RF; van Puijenbroek EP
Regul Toxicol Pharmacol; 2012 Aug; 63(3):409-17. PubMed ID: 22609380
[TBL] [Abstract][Full Text] [Related]
2. Cosmetovigilance: definition, regulation and use "in practice".
Vigan M; Castelain F
Eur J Dermatol; 2014; 24(6):643-9. PubMed ID: 25672787
[TBL] [Abstract][Full Text] [Related]
3. Assessment of undesirable events in cosmetic market surveillance: background, description and use of a causality assessment method in cosmetovigilance.
Bons B; Audebert F; Bitaudeau C; Cachin N; Colson L; Farr C; Fix LA; Gilmour N; Gorni R; Griffiths M; Harris B; Holle V; Kirk S; Meredith E; Pari C; Poinsot P; Renner G;
Regul Toxicol Pharmacol; 2010 Dec; 58(3):349-53. PubMed ID: 20619309
[No Abstract] [Full Text] [Related]
4. Analysis and Reporting of Adverse Drug Reactions of Cosmetics at a Tertiary Care Hospital.
Paikray E; Bisoyi D; Rout A; Mishra V
Cureus; 2024 Mar; 16(3):e56856. PubMed ID: 38659521
[TBL] [Abstract][Full Text] [Related]
5. European consumer exposure to cosmetic products, a framework for conducting population exposure assessments.
Hall B; Tozer S; Safford B; Coroama M; Steiling W; Leneveu-Duchemin MC; McNamara C; Gibney M
Food Chem Toxicol; 2007 Nov; 45(11):2097-108. PubMed ID: 17683841
[TBL] [Abstract][Full Text] [Related]
6. Cosmetovigilance in a tertiary care hospital: A prospective observational study.
Jyrwa S; Sebastian J; Shastry V
J Cosmet Dermatol; 2021 Mar; 20(3):804-811. PubMed ID: 32808451
[TBL] [Abstract][Full Text] [Related]
7. European consumer exposure to cosmetic products, a framework for conducting population exposure assessments Part 2.
Hall B; Steiling W; Safford B; Coroama M; Tozer S; Firmani C; McNamara C; Gibney M
Food Chem Toxicol; 2011 Feb; 49(2):408-22. PubMed ID: 21093525
[TBL] [Abstract][Full Text] [Related]
8. [Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future].
Tissier MH; Lepagnol F
Therapie; 2002; 57(3):273-82. PubMed ID: 12422542
[TBL] [Abstract][Full Text] [Related]
9. The impact of COLIPA guidelines for assessment of skin compatibility on the development of cosmetic products.
Meloni M; Berardesca E
Am J Clin Dermatol; 2001; 2(2):65-8. PubMed ID: 11705305
[TBL] [Abstract][Full Text] [Related]
10. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
[TBL] [Abstract][Full Text] [Related]
11. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
12. Probabilistic modelling of European consumer exposure to cosmetic products.
McNamara C; Rohan D; Golden D; Gibney M; Hall B; Tozer S; Safford B; Coroama M; Leneveu-Duchemin MC; Steiling W
Food Chem Toxicol; 2007 Nov; 45(11):2086-96. PubMed ID: 17804138
[TBL] [Abstract][Full Text] [Related]
13. Post Launch Monitoring of food products: what can be learned from pharmacovigilance.
van Puijenbroek EP; Hepburn PA; Herd TM; van Grootheest AC
Regul Toxicol Pharmacol; 2007 Mar; 47(2):213-20. PubMed ID: 17204356
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme.
Lea LJ; Hepburn PA
Food Chem Toxicol; 2006 Aug; 44(8):1213-22. PubMed ID: 16542769
[TBL] [Abstract][Full Text] [Related]
15. A cosmetovigilance survey in Europe.
Sautebin L
Pharmacol Res; 2007 May; 55(5):455-60. PubMed ID: 17368906
[TBL] [Abstract][Full Text] [Related]
16. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
18. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring cosmetic product safety].
Vigan M
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S55-8. PubMed ID: 17563716
[No Abstract] [Full Text] [Related]
20. Contact allergy to hair colouring products. The cosmetovigilance experience of 4 companies (2003-2006).
Krasteva M; Bons B; Tozer S; Rich K; Hoting E; Hollenberg D; Fuchs A; Fautz R
Eur J Dermatol; 2010; 20(1):85-95. PubMed ID: 19797040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
